Artificial intelligence can prevent the diagnosis of medicine

Artificial intelligence can prevent the diagnosis of medicine

Artificial intelligence can prevent the diagnosis of medicine

Artificial intelligence can prevent the diagnosis of medicine

The Alphabet project can predict when a patient will get worse by working hand-in-hand with Alphabet, Google’s parent company, and the U.S. Department of Veterans to take the technology to the rooms of patients to monitor and monitor possible changes in the elderly’s health status.

This union, however, is not about electronic devices to monitor heartbeat or blood pressure or tension control, but both companies are working on deploying DeepMind, Alphabet’s artificial intelligence.

According to several medical studies, one out of ten hospital deaths occurs after any change in the health status of the patient has been avoided.

Smartphones and minors: greater use, greater risk exposure and less damage

The Alphabet project and the U.S. administration will analyze patterns of 700,000 anonymous medical records to see if DeepMind’s Artificial Intelligence can identify which patients will get worse during hospital admission and find out how their future physician DeepMind and its engineers can use the technology to detect early-stage kidney failure.

Kidney injuries commonly occur after routine procedures and operations, such as hip replacement, and often suddenly appear without obvious signs of warning. These injuries can be life-threatening, so in the hope of saving patients, they say, DeepMind wants to find ways to detect them early.

This Alphabet and DeepMind medical incursion is not the first. The’ smart’ division of the matrix of the search engine giant is capable of diagnosing eye diseases with great accuracy and detecting pathologies.

The system relies on medical scanners and retinal scans trained algorithms to detect any problem faster and more effectively.

It is the first application of health relevance, and it could soon begin to be tested in clinical trials if it gets regulators ‘ approval. According to Accenture, the advances applied to medicine in artificial intelligence could save the industry up to $150,000 million by 2026.

Leave a comment

* - Required fields